BioSyent Adopts Advance Notice By-law
MISSISSAUGA, Ontario, Feb. 11, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
News
Vaxxinity’s COVID-19 Vaccine Candidate UB-612 Produces High Levels of Neutralizing Antibodies Against Omicron and Other Variants of Concern
Investigator-sponsored studies show UB-612 induces high antibody activity against multiple variants, including Alpha, Beta, Delta,…
Amolyt Pharma to Participate at Three Upcoming Investor Conferences
LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Amolyt Pharma, a global…
Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for Omburtamab
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Coherus BioSciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 17th, 2022
REDWOOD CITY, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today…
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage…
NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaper BriLife vaccine…
Replimune to Present at the 11th Annual SVB Leerink Global Healthcare Conference
WOBURN, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…
Vor to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR), a clinical-stage cell…
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
SCOTTSDALE, Ariz., Feb. 11, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”),…
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
Immutep Granted Australian Patent for Eftilagimod Alpha, a Soluble LAG-3 Protein, in Combination with a PD-1 Pathway Inhibitor
SYDNEY, AUSTRALIA, Feb. 11, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Spectral Medical Reports Progress on Tigris Clinical Trial
Patient mortality data continues to exceed expectations Recent FDA approved SOFA amendment contributing to increased…
Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference
WALTHAM, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
Keros Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
LEXINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (NASDAQ: KROS), a…
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Sensei Biotherapeutics to Participate in Citi’s 2022 Virtual Immuno-Oncology Summit
BOSTON, Feb. 11, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company…
PARSIQ and IQ Protocol Sponsor the ETHDenver Hackathon to Accelerate Mass Adoption of Web3.0
Tallinn, Estonia–(Newsfile Corp. – February 11, 2022) – In February 2022, PARSIQ and IQ Labs…
Apollo Shareholders Relations Announces Official Company Launch
Vancouver, British Columbia–(Newsfile Corp. – February 11, 2022) – Apollo Shareholder Relations (“Apollo”), a full-service…
Harris Williams Advises Alcumus Group Limited on its Pending Sale to Apax Partners LLP
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…